SMSI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. Price action and trend indicators are bearish, there are no Intellectia buy signals to override that, and fundamentals show ongoing revenue decline and widening losses. For an impatient investor looking for immediate upside, SMSI is an avoid/sell until it reclaims key resistance levels and momentum improves.
Trend is bearish: SMA_200 > SMA_20 > SMA_5 confirms a persistent downtrend. MACD histogram (-0.00127) is below zero and negatively expanding, signaling downside momentum is increasing rather than stabilizing. RSI_6 at ~32.6 is near oversold territory but not showing a clear reversal signal by itself. Key levels: immediate support is S2 ~0.534 then S1 ~0.555; price at 0.545 is sitting just above deeper support. Overhead resistance is the pivot ~0.589, then R1 ~0.624—price would need to break and hold above ~0.589 to improve the short-term setup. The pattern-based projection suggests only small expected gains (about +0.2% next day, +1.79% next week), which is not compelling given the downtrend.
No news in the last week, so no near-term event catalyst identified. Potential technical catalyst would be a reversal signal: holding above ~0.534 support and reclaiming the pivot at ~0.589 with improving MACD/RSI. Options open interest skew is bullish (call-heavy), which could support a short-lived bounce if buyers step in.
No positive news flow recently. Technical momentum is weakening (MACD negative and expanding) and the moving-average stack is bearish, increasing odds of support breaks. Very high implied volatility suggests the market expects instability; for shares, that often coincides with persistent selling pressure in distressed small caps. Financial results show continued declines in revenue and larger losses, which can keep sentiment negative without a clear turnaround catalyst.
Latest quarter (2025/Q3): Revenue fell to $4.347M (-6.48% YoY). Net income was -$5.17M (loss worsened; -18.83% YoY). EPS was -$0.25 (down -53.70% YoY). The one bright spot is gross margin improving to 42.88% (+4.61% YoY), but profitability is still deeply negative and top-line contraction continues—overall not supportive of a near-term bullish re-rate.
No analyst rating or price target change data was provided, so a Wall Street consensus/pros-and-cons summary cannot be validated from the dataset. Based on the available data alone, the bear case dominates (downtrend + deteriorating earnings), while the bull case is limited to a potential oversold bounce and improved gross margin.
